The company operates in the home healthcare sector, delivering clinical support at patients' residences. Its model is designed to provide continuity of care for patients who are clinically suitable for treatment outside a hospital environment, combining assessment, follow-up and delivery of prescribed therapies.
Established in 2021, the business has developed an operating presence in the Lisbon area and a service offering centred on home-based healthcare. The operation is supported by a sector-experienced team and a relatively light physical infrastructure, which may support operational flexibility as demand scales.
- Home healthcare: clinical support for eligible patients outside hospital settings, focused on continuity of care and avoiding unnecessary travel.
- Acute infection management: reported capability to follow selected respiratory, urinary and skin/soft-tissue infection cases, subject to clinical and operational eligibility criteria.
- Chronic disease follow-up: services linked to decompensated chronic conditions, including COPD, heart failure and diabetes.
- Post-operative care: follow-up after surgical procedures, including home recovery support and complex wound care.
- Home-delivered therapies: services include intravenous antibiotic therapy, oxygen therapy and symptom management, subject to applicable clinical conditions and safety procedures.
- Diversified commercial base: customer portfolio split between insurers and private clients, offering the potential to combine institutional referrals with direct contracting.
- Team and know-how: reported qualified team with experience in clinical service delivery, a key factor in a sector driven by trust, technical quality and continuity of care.
- Development potential: potential to strengthen partnerships with hospitals, clinics and other organisations, develop remote monitoring and broaden geographic coverage, subject to investment and execution.
pt 
